Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;55(1):132-4.
doi: 10.1097/QAI.0b013e3181d5a800.

Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371

Carrie Dykes, A Lisa Mukherjee, Ronald J Bosch, Elizabeth Connick, Paul A Volberding, Lisa M Demeter

Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371

Carrie Dykes et al. J Acquir Immune Defic Syndr. 2010 Sep.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Booth CL, Geretti AM. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection. J Antimicrob Chemother. 2007 Jun;59(6):1047–1056. - PubMed
    1. Little SJ, Frost SD, Wong JK, et al. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol. 2008 Jun;82(11):5510–5518. - PMC - PubMed
    1. Jain V, Susupira C, Deeks S, et al. Persistence of Transmitted Drug-resistance Mutations in Patients with Acute HIV. 16th Conference on Retroviruses and Opportunistic Infections; Montreal, Canada. 2009.
    1. Simon V, Padte N, Murray D, et al. Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection. J Virol. 2003 Jul;77(14):7736–7745. - PMC - PubMed
    1. Wainberg MA. The impact of the M184V substitution on drug resistance and viral fitness. Expert Review of Antiinfective Therapy. 2004;2(1):147–151. - PubMed

Publication types

MeSH terms

Substances